Search results
City of Hope patients have access to a wide variety of lung cancer clinical trials such as the newest immunotherapy treatment and targeted therapy approaches — all with the goal of helping extend life.
- Cancer Immunotherapeutics
Scientists in City of Hope’s Cancer Immunotherapeutics...
- Cancer Immunotherapeutics
The purpose of this study is to test the safety and effectiveness of radiation therapy followed by atezolizumab and find out what side effects, if any, it has on patient's non-small cell lung cancer.
Search our clinical trials. City of Hope is committed to providing new and innovative treatments for our cancer patients whenever possible. This includes enrolling qualified patients in carefully selected clinical trials for cancer.
Scientists in City of Hope’s Cancer Immunotherapeutics Program (CI) are focused on finding new ways to use an old weapon to treat cancer. Researchers here concentrate on discovering new methods of inciting the human immune system to attack tumor cells.
24 paź 2024 · Team City of Hope and 5-Year Updated CROWN Data. Presented by Erminia Massarelli, MD, PhD, MS. Investigators presented 5-year efficacy data from the phase 3 CROWN trial (NCT03052608 ) at the 2024 American Society of Clinical Oncology Annual Meeting. 1 The trial assessed patients with ALK -positive NSCLC being treated with lorlatinib (Lorbrena ...
Any systemic anti-tumor therapy such as chemotherapy, immunotherapy and radiation therapy used within 4 weeks prior to enrollment; any palliative radiotherapy for non-target lesions used to relieve symptoms and traditional Chinese medicines indicated for tumor within 2 weeks prior to enrollment.
By focusing primarily on the development of groundbreaking ways to treat and care for people with cancer, City of Hope has been able to transform the future of lung health. Current clinical trials include: EARLY STAGE/LOCALLY ADVANCED TRIALS • A Phase III, Randomized, Controlled, Multicenter, 3 Arm
